Drugs / recombinant human Follicle-Stimulating Hormone (r-FSH-alfa)
recombinant human Follicle-Stimulating Hormone (r-FSH-alfa)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT06778733 Comparator | Jan 2022 → Jan 2024 | female infertility | University of Athens | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant human Follicle-Stimulating Hormone (r-FSH-alfa) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06778733 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human Follicle-Stimulating Hormone (r-FSH-alfa)” NCT06778733 ↗ |